science-product-detail
DOI https://doi.org/10.1007/s10815-017-0891-9
Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles
Thi Ngoc Lan Vuong1,2, M. T. Ho2,3, T. Q. Ha2, M. Brehm Jensen4, C. Yding Andersen4, P. Humaidan5,6
Purpose
A recent dose-finding study showed no significant differences in number of mature oocytes, embryos and top-quality embryos when triptorelin doses of 0.2, 0.3 or 0.4 mg were used to trigger final oocyte maturation in oocyte donors co-treated with a gonadotropin-releasing hormone (GnRH) antagonist. This analysis investigated whether triptorelin dosing for triggering final oocyte maturation in oocyte donors induced differences in follicular fluid (FF) hormone levels and granulosa cell gene expression.
Methods
This single-centre, randomised, parallel, investigator-blinded trial was conducted in oocyte donors undergoing a single stimulation cycle at IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam, from August 2014 to March 2015. A total of 165 women aged 18–35 years with body mass index <28 kg/m2, anti-Müllerian hormone >1.25 ng/mL, and antral follicle count ≥6 were randomised to three different triptorelin doses for trigger. The main outcome was concentration of steroid hormones in FF collected from the first punctured follicle on each side. Moreover, luteinising hormone receptor (LHR), 3β-hydroxy-steroid-dehydrogenase (3ßHSD) and inhibin-Ba (INHB-A) gene expression in cumulus and mural granulosa cells were investigated in a subset of women from each group.
Results
Progesterone and oestradiol levels in FF did not differ significantly by trigger doses; findings were similar for 3βHSD, LHR and INHB-A gene expression in both cumulus and mural granulosa cells.
Conclusions
In women co-treated with a GnRH antagonist, no significant differences in FF steroid levels and granulosa cell gene expression were seen when different triptorelin doses were used to trigger final oocyte maturation.
KEYWORDS:
In vitro fertilisation Gonadotropin-releasing hormone agonist trigger LHR gene expression Triptorelin Follicular fluid
Download
Similar articles
-
Review A cost-effectiveness analysis of freeze only or fresh embryo transfer in IVF of non-PCOS women
[ Le KD1, Vuong LN1,2, Ho TM1, Dang VQ1, Pham TD1, Pham CT3, Norman RJ4,5, Mol BWJ6. ]
STUDY QUESTION
Is a freeze-only strategy more cost-effective from a patient perspective than fresh embryo transfe... -
Review Effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilisation in women with high antral follicle count: study protocol for a randomised controlled trial
[ Lan N Vuong1,2, Vu N A Ho2, Tuong M Ho2, Vinh Q Dang2, Tuan H Phung2, Nhu H Giang2, Anh H Le2, Toan D Pham2, Rui Wang3, Rob J Norman3,4, Johan Smitz5, Robert B Gilchrist6, Ben W Mol7 ]
Introduction In vitro maturation (IVM) is a potential alternative to conventional in vitro fertilisation (IVF) to avoi...
-
Review Blastocyst Prediction of Day-3 Cleavage-Stage Embryos Using Machine Learning
[ Dung P. Nguyen 1,2, Quan T. Pham 2, Thanh L. Tran 1,2, Lan N. Vuong 2,3,4, Tuong M. Ho 2,3 ]
Background: Embryo selection plays an important role in the success of in vitro fertilization (IVF). However, morphological e...
-
Review Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte
[ Ali Abbara1, Lan N. Vuong2,3, Vu N. A. Ho3, Sophie A. Clarke1, Lisa Jeffers1, Alexander N. Comninos1, Rehan Salim4, Tuong M. Ho3, Tom W. Kelsey5, Geoffrey H. Trew4, Peter Humaidan6and Waljit S. Dhillo1 ]
Objective: To identify follicle sizes on the day of trigger most likely to yield a mature oocyte following hCG, GnRH a...
-
Review Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study
[ J M N Duffy 1 2, S Bhattacharya 3, S Bhattacharya 3, M Bofill 4, B Collura 5, C Curtis 6 7, J L H Evers 8, L C Giudice 9 10, R G Farquharson 11, S Franik 12, M Hickey 13, M L Hull 14, V Jordan 4, Y Khalaf 15, R S Legro 16, S Lensen 13, D Mavrelos 17, B W Mol 18, C Niederberger 19, E H Y Ng 20 21, L Puscasiu 22, S Repping 23 24, I Sarris 1, M Showell 25, A Strandell 26, A Vail 27, M van Wely 23, M Vercoe 25, N L Vuong 28, A Y Wang 29, R Wang 18, J Wilkinson 27, M A Youssef 30, C M Farquhar 4 25, Core Outcome Measure for Infertility Trials (COMMIT) initiative ]
Study question: Can consensus definitions for the core outcome set for inferti...
https://doi.org/10.1093/humrep/deaa243